Position in NVAX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$645,081
+$189,331 QoQ
Shares Held
68,480
+22.3% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#79
of 263 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AXQ CAPITAL, LP holds $45,364,119 across 106 Biotechnology names. NVAX ranks #21 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
91,437 | $3,566,957 | |
| 2 | INSM |
INSMED Inc
|
22,813 | $2,432,322 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
30,831 | $2,413,142 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,952 | $1,840,690 | |
| 5 | MRNA |
Moderna, Inc.
|
22,477 | $1,574,064 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
39,712 | $1,405,407 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,797 | $1,389,353 | |
| 8 | SMMT |
Summit Therapeutics Inc.
|
93,624 | $1,364,101 |
All Filings in NVAX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $645,081 | 68,480 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $455,750 | 55,989 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $201,378 | 29,967 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $444,432 | 51,261 | Shares | Sole | 2025-11-10 | |
| 2025-03-31 | $88,656 | 13,831 | Shares | Sole | 2025-05-13 | |
| 2023-06-30 | $132,254 | 17,800 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $96,922 | 13,986 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||